15/12/2025
GluCare - Dubai pioneering a study on early detection of Diabetic Kidney Disease (DKD) employing innovative biomarker (DNlite from BPM) -The uPTM-FetA test is designed to detect this signal early, sometimes one to two years before changes appear in commonly used markers such as UACR or eGFR.
GluCare.Health introduces an early biomarker test for diabetic kidney disease in the UAE, enabling earlier detection, personalised care, and improved outcomes for people with diabetes.